Top Markets
Coin of the day
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc.

ADGI
Rankning i aktier #16423
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily... Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily focused on the discovery, development, and subsequent commercialization of antibody-based therapeutics designed to combat infectious diseases across the United States. Its most advanced product candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical trials. This antibody is being evaluated for both the treatment and prevention of coronavirus disease. Adagio Therapeutics also engages in strategic collaborations. It partners with Adimab, LLC to facilitate the discovery and optimization of novel proprietary antibodies. Furthermore, the company works with the Scripps Research Institute on research initiatives aimed at identifying vaccine candidates that could prevent, diagnose, or treat influenza and beta coronaviruses. Founded in 2020, Adagio Therapeutics maintains its headquarters in Waltham, Massachusetts.
Aktiekurs
$4.64
Senast synkroniserad: 2022-09-12
Marknadsvärde
$293.43M
Förändring (1 dag)
0.87%
Förändring (1 år)
0.00%
Land
US
Handel Adagio Therapeutics, Inc. (ADGI)

Kategori

Historik för aktiesplit för Adagio Therapeutics, Inc. (ADGI)
Aktien Adagio Therapeutics, Inc. (symbol: ADGI) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Sep 02, 2026.
En ADGI-aktie köpt före Sep 02, 2026 motsvarar nu 0 ADGI-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH